Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b+/Gr-1+ myeloid cells depletion using a recombinant peptibody in 4 T1-HER2 tumor model

Autor: Ramezani-Aliakbari, Khadijeh, Khaki-Bakhtiarvand, Vahid, Mahmoudian, Jafar, Asgarian-Omran, Hossein, Shokri, Fazel, Hojjat-Farsangi, Mohammad, Jeddi-Tehrani, Mahmood, Shabani, Mahdi
Zdroj: In International Immunopharmacology August 2023 121
Databáze: ScienceDirect